Revolutionary Breakthrough: TRX103’s FDA Clearance Pioneers Allogeneic T-Cell Therapy for Autoimmune Diseases Read More »
Revolutionizing ALS Treatment: BrainStorm’s Phase 3b Trial Moves Forward with FDA Approval Read More »